Peter C. Gøtzsche

Peter C. Gøtzsche is a Danish physician, medical researcher, and former director of the Nordic Cochrane Center who has become known for his critical analysis of medical research practices and the pharmaceutical industry. His work has focused extensively on systematic reviews, research methodology, and exposing what he views as systemic problems in medical research. As a co-founder of the Cochrane Collaboration in 1993, Gøtzsche played a significant role in developing methods for systematic reviews of medical treatments and interventions. He later became embroiled in controversy and was expelled from the organization in 2018 after disputes over his critiques of psychiatric medications and mammography screening programs. Gøtzsche has authored several influential books including "Deadly Medicines and Organised Crime: How Big Pharma Has Corrupted Healthcare" and "Deadly Psychiatry and Organised Denial." His publications have challenged established medical practices and sparked debates about pharmaceutical industry influence on healthcare. After his departure from Cochrane, Gøtzsche established the Institute for Scientific Freedom and continues to publish research and commentary on evidence-based medicine, research integrity, and healthcare reform. His work has been published in major medical journals including The Lancet, British Medical Journal, and Journal of the American Medical Association.

Readers view Gøtzsche as a polarizing medical researcher who challenges pharmaceutical industry practices. His works attract both fierce defenders and critics. Readers appreciate: - Detailed documentation and extensive references - Clear explanations of complex medical statistics - Exposure of pharmaceutical industry misconduct - Focus on patient advocacy Common criticisms: - Combative and accusatory tone - Cherry-picking of evidence - Overly harsh stance against psychiatry - Repetitive arguments across books Ratings across platforms: Goodreads: "Deadly Medicines and Organised Crime" - 4.3/5 (1,200+ ratings) "Deadly Psychiatry and Organised Denial" - 4.4/5 (400+ ratings) Amazon: "Survival in an Overmedicated World" - 4.6/5 (150+ ratings) Reader quote: "Important information but the angry tone undermines credibility" - Goodreads reviewer Counter quote: "His bluntness is necessary given the gravity of pharmaceutical industry corruption" - Amazon reviewer

Deadly Medicines and Organised Crime: How Big Pharma Has Corrupted Healthcare (2013) A detailed examination of pharmaceutical industry practices, documenting cases of research manipulation, marketing strategies, and their impact on healthcare systems.

Deadly Psychiatry and Organised Denial (2015) An analysis of psychiatric drug use, examining clinical trial data and questioning current practices in mental health treatment.

Survival in an Overmedicated World: Look Up the Evidence Yourself (2019) A guide to understanding medical research and evaluating health information independently using evidence-based approaches.

Mental Health Survival Kit and Withdrawal from Psychiatric Drugs (2020) A systematic examination of psychiatric drug withdrawal methods and alternatives to long-term medication use.

Vaccines: Truth, Lies, and Controversy (2021) An investigation of vaccine research, development, and policy, analyzing clinical trial data and public health decisions.

The Chinese Virus: Killed Millions and Scientific Freedom (2022) An examination of global pandemic responses and their impact on scientific discourse and public health policy.

Ben Goldacre writes extensively about flaws in medical research and pharmaceutical industry practices. He has published investigations into clinical trial transparency and evidence distortion in medicine through books like "Bad Science" and "Bad Pharma."

Marcia Angell served as editor-in-chief of the New England Journal of Medicine and examines pharmaceutical industry influence on medical research. Her work "The Truth About Drug Companies" details how marketing priorities affect drug development and clinical practice.

David Healy researches pharmaceutical industry practices and psychiatric medication risks as a psychiatrist and historian. He has documented issues with selective publication of clinical trials and adverse effects of psychotropic drugs through extensive academic work and books.

Jerome Kassirer analyzes conflicts of interest in medicine based on his experience as former editor of the New England Journal of Medicine. His book "On the Take" examines how financial relationships between physicians and industry impact medical practice and research.

John Abramson investigates pharmaceutical marketing practices and evidence manipulation in medical research through systematic analysis. His work "Overdosed America" examines how commercial influences shape drug development and clinical guidelines.